Who We Help.
Leaders on both sides of the healthcare technology table — inside health systems and inside the companies building for them.
Health systems & hospitals
Modernization pressure is rising — AI, ambient, workforce, and EHR optimization — while clinician capacity is flat and the cost of a failed bet is high.
- Sequence technology, workflow, and change against real operating capacity
- Design adoption and governance before procurement, not after
- Recover stalled implementations without restarting the program
- A defensible transformation roadmap
- Adoption that holds across service lines
- Board-ready ROI and clinical impact
Provider groups
Independent groups carry the same technology pressure as health systems with less centralized capacity and tighter margins.
- Right-size the technology portfolio to the group's operating model
- Stand up adoption and governance without enterprise overhead
- Build the value story for partners, payers, and capital
- Focused investment, less waste
- Adoption that protects clinician retention
- Clearer value narrative for partners and investors
Healthcare AI & SaaS companies
Selling and shipping isn't the hard part anymore — sustaining adoption, proving value, and protecting renewal is.
- Build the Customer Success operating model and VOC system
- Design adoption and value-realization playbooks the delivery team can run
- Reframe the value narrative the buyer actually defends internally
- Adoption that holds after the launch glow fades
- Earlier signal on renewal and expansion
- Repeatable proof for board and customer reviews
Medtech & surgical technology
Device, capital, and surgical-tech sales are increasingly conditional on workflow fit, evidence, and post-launch adoption — not just clinical preference.
- Workflow-fit and adoption design across surgical and procedural environments
- Customer Success and value realization motions tied to utilization
- Executive narrative that connects clinical, operational, and financial value
- Higher post-sale utilization
- Stronger renewal and capital reinvestment
- Clinical champions who stay champions
Biopharma & life sciences partners
Partnerships with health systems and provider groups stall when workflow, governance, and value haven't been designed end-to-end.
- Design partnership programs that fit clinical and operational reality
- Stand up shared governance and evidence frameworks
- Build the operating cadence that keeps partnerships measurable
- Partnerships that survive leadership change
- Measurable clinical and commercial outcomes
- Stronger reinvestment and expansion conversations
Investors, boards & portfolio leaders
Adoption risk is now the single largest gap between healthcare technology valuation and realized value.
- Adoption and value diligence on prospective or current investments
- Operator-level review of CS, implementation, and value-realization capability
- Board-ready narrative on what to fund, fix, or hold
- Sharper view of adoption risk before and after the check
- Targeted operating playbooks for portfolio companies
- Confidence in the value story the company is telling the market
Not Sure Where You Fit?
Tell us what's actually happening — we'll match it to the right shape of work.